CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 301563-301869 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2320","span":{"begin":0,"end":306},"obj":"Sentence"},{"id":"T58231","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Also in development are two additional carbapenems, ME1036, in Phase I studies, with activity against MRSA as well as against most Enterobacteriaceae, and SMP-601/PZ-601 that has demonstrated in vitro activity against many multidrug-resistant Gram-positive and Gramnegative bacteria in preclinical studies."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T56","span":{"begin":0,"end":306},"obj":"Sentence"}],"text":"Also in development are two additional carbapenems, ME1036, in Phase I studies, with activity against MRSA as well as against most Enterobacteriaceae, and SMP-601/PZ-601 that has demonstrated in vitro activity against many multidrug-resistant Gram-positive and Gramnegative bacteria in preclinical studies."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1038","span":{"begin":102,"end":106},"obj":"Disease"},{"id":"T10029","span":{"begin":102,"end":106},"obj":"Disease"}],"attributes":[{"id":"A1038","pred":"mondo_id","subj":"T1038","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A63287","pred":"mondo_id","subj":"T10029","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"Also in development are two additional carbapenems, ME1036, in Phase I studies, with activity against MRSA as well as against most Enterobacteriaceae, and SMP-601/PZ-601 that has demonstrated in vitro activity against many multidrug-resistant Gram-positive and Gramnegative bacteria in preclinical studies."}